NO995349L - Multivalent vaksinasjonssammensetning med blandet baerer - Google Patents

Multivalent vaksinasjonssammensetning med blandet baerer

Info

Publication number
NO995349L
NO995349L NO995349A NO995349A NO995349L NO 995349 L NO995349 L NO 995349L NO 995349 A NO995349 A NO 995349A NO 995349 A NO995349 A NO 995349A NO 995349 L NO995349 L NO 995349L
Authority
NO
Norway
Prior art keywords
vaccine composition
multivalent vaccine
mixed carrier
polyosides
conjugates
Prior art date
Application number
NO995349A
Other languages
English (en)
Other versions
NO320415B1 (no
NO995349D0 (no
Inventor
Odile Leroy
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9507086&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995349(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of NO995349L publication Critical patent/NO995349L/no
Publication of NO995349D0 publication Critical patent/NO995349D0/no
Publication of NO320415B1 publication Critical patent/NO320415B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO19995349A 1997-05-14 1999-11-02 Multivalent vaksinesammensetning med blandet baerer NO320415B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706210A FR2763244B1 (fr) 1997-05-14 1997-05-14 Composition vaccinale multivalente a porteur mixte
PCT/FR1998/000966 WO1998051339A1 (fr) 1997-05-14 1998-05-14 Composition vaccinale multivalente a porteur mixte

Publications (3)

Publication Number Publication Date
NO995349L true NO995349L (no) 1999-11-02
NO995349D0 NO995349D0 (no) 1999-11-02
NO320415B1 NO320415B1 (no) 2005-12-05

Family

ID=9507086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995349A NO320415B1 (no) 1997-05-14 1999-11-02 Multivalent vaksinesammensetning med blandet baerer

Country Status (20)

Country Link
US (2) US7862823B1 (no)
EP (1) EP0983087B1 (no)
JP (1) JP2001525815A (no)
KR (1) KR100709628B1 (no)
CN (1) CN1154509C (no)
AT (1) ATE279942T1 (no)
AU (1) AU748716B2 (no)
BR (1) BR9808772A (no)
CA (1) CA2289009C (no)
CZ (1) CZ295272B6 (no)
DE (1) DE69827127T2 (no)
ES (1) ES2227840T3 (no)
FR (1) FR2763244B1 (no)
HU (1) HUP0002322A3 (no)
IL (3) IL132669A0 (no)
NO (1) NO320415B1 (no)
NZ (1) NZ500738A (no)
PL (1) PL189653B1 (no)
PT (1) PT983087E (no)
WO (1) WO1998051339A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
CN100339130C (zh) * 1999-03-19 2007-09-26 史密丝克莱恩比彻姆生物有限公司 疫苗
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0130215D0 (en) * 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
FR2850106B1 (fr) 2003-01-17 2005-02-25 Aventis Pasteur Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
BRPI0510315A (pt) 2004-04-30 2007-10-16 Chiron Srl integração de vacinação com conjugado meningocócico
GB0419846D0 (en) * 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425856A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
HUE045482T2 (hu) 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
JP5135220B2 (ja) 2005-09-01 2013-02-06 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー 血清群ｃ髄膜炎菌を含む複数ワクチン接種
MY150719A (en) 2005-12-22 2014-02-28 Glaxosmithkline Biolog Sa Pneumococcal polysaccharide conjugate vaccine
TW200806315A (en) 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
AU2008248640A1 (en) 2007-05-02 2008-11-13 Glaxosmithkline Biologicals S.A. Vaccine
EP2170391B1 (en) * 2007-06-20 2017-01-18 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
US9610340B2 (en) 2007-06-26 2017-04-04 Glaxosmithkline Biologicals, S.A. Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
US20130071422A1 (en) 2010-03-18 2013-03-21 Michele Pallaoro Adjuvanted vaccines for serogroup b meningococcus
BR112013005049A2 (pt) 2010-09-02 2016-05-31 Sanofi Pasteur estabilizador para a preparação de uma composição vacina da pólio seca injetável
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
HUE040914T4 (hu) * 2012-01-30 2019-05-28 Serum Institute Of India Pvt Ltd Immunogén készítmény
ES2773954T3 (es) 2012-10-03 2020-07-15 Glaxosmithkline Biologicals Sa Composición inmunogénica
WO2016012385A1 (en) 2014-07-21 2016-01-28 Sanofi Pasteur Vaccine composition comprising ipv and cyclodextrins
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN105695497B (zh) 2014-11-27 2019-09-24 中国人民解放军军事医学科学院生物工程研究所 一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
AU2016285017B2 (en) 2015-06-23 2022-03-03 Biological E Limited Multivalent pneumococcal conjugate vaccine
WO2018027126A1 (en) * 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3031797A1 (en) * 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3037056A1 (en) 2016-09-30 2018-04-05 Biological E Limited Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2018227177A1 (en) 2017-06-10 2018-12-13 Inventprise, Llc Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
CA3087572A1 (en) * 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
JP6950099B2 (ja) 2018-02-05 2021-10-13 サノフィ パスツール インコーポレイティッド 多価肺炎球菌多糖体−タンパク質複合体組成物
JP2021522213A (ja) 2018-04-18 2021-08-30 エスケー バイオサイエンス カンパニー リミテッド ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
JP7399934B2 (ja) 2018-07-04 2023-12-18 バックスサイト・インコーポレイテッド 免疫原性複合体の改良
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2023200704A1 (en) 2022-04-11 2023-10-19 Sanofi Pasteur Inc. Protein-saccharide conjugation with sodium cyanoborohydride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CN100339130C (zh) 1999-03-19 2007-09-26 史密丝克莱恩比彻姆生物有限公司 疫苗
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
ES2227840T3 (es) 2005-04-01
CN1255861A (zh) 2000-06-07
IL132669A (en) 2010-11-30
PL189653B1 (pl) 2005-09-30
US8029798B2 (en) 2011-10-04
AU7773098A (en) 1998-12-08
IL132669A0 (en) 2001-03-19
DE69827127D1 (de) 2004-11-25
FR2763244A1 (fr) 1998-11-20
HUP0002322A3 (en) 2001-12-28
IL183296A0 (en) 2007-09-20
KR20010012477A (ko) 2001-02-15
DE69827127T2 (de) 2005-03-24
PT983087E (pt) 2005-01-31
ATE279942T1 (de) 2004-11-15
HUP0002322A2 (hu) 2000-11-28
JP2001525815A (ja) 2001-12-11
NO320415B1 (no) 2005-12-05
CZ295272B6 (cs) 2005-06-15
PL336704A1 (en) 2000-07-03
CA2289009A1 (fr) 1998-11-19
US20110117123A1 (en) 2011-05-19
FR2763244B1 (fr) 2003-08-01
BR9808772A (pt) 2000-09-05
NZ500738A (en) 2002-03-28
CN1154509C (zh) 2004-06-23
EP0983087B1 (fr) 2004-10-20
WO1998051339A1 (fr) 1998-11-19
CZ9904021A3 (en) 2001-06-13
EP0983087A1 (fr) 2000-03-08
US7862823B1 (en) 2011-01-04
CA2289009C (fr) 2011-04-26
AU748716B2 (en) 2002-06-13
KR100709628B1 (ko) 2007-04-19
NO995349D0 (no) 1999-11-02

Similar Documents

Publication Publication Date Title
NO995349L (no) Multivalent vaksinasjonssammensetning med blandet baerer
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
FR2841900B1 (fr) Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations
BR0012243A (pt) Triflúor butenos nematocidas
EE200000320A (et) Uudsed ühendid
DK0915898T3 (da) Krystalform I af clarithromycin
EE201000020A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
NO20002786L (no) Adamantanderivater
PT842934E (pt) Agonistas de 5-ht1f
ATE231872T1 (de) Thiazolopyrimidinderivate
SE9802937D0 (sv) Novel compounds
ID25478A (id) Agonis 5-ht1f
NO995858D0 (no) Ny klasse kationiske nukleinsyre-overföringsmidler
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
ATE171072T1 (de) Rezeptor-konjugate zum targeting von arzneiwirkstoffen und anderen wirksubstanzen
ITPD20000235A0 (it) Sistema di stiratura denominata "vibrostiro facile" per tavolo da stiro od altro.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees